Pharmaceutical - Financial, Actavis

Filter

Current filters:

FinancialActavis

Popular Filters

EU Commission fines Lundbeck and other Pharmas over "pay-for-delay" deals

19-06-2013

In a much awaited decision following its investigations of patent settlements (or pay-for-delay deals)…

ActaviscitalopramEuropeFinancialGenericsLegalLundbeckMerck KGaAMylan LaboratoriesNeurologicalPatentsPharmaceuticalRanbaxy Laboratories

Actavis and Warner Chilcott leap on merger talks; possible bid for Adcock Ingram

13-05-2013

US generics major Actavis NYSE: ACT) confirmed on Friday (May 10) that it has entered into early stage…

ActavisAdcock IngramFinancialGenericsMergers & AcquisitionsPharmaceuticalWarner Chilcott

QRxPharma value assed as Actavis deal finalized

29-03-2012

Australian company QRxPharma (ASX: QRX) is moving rapidly towards the commercial phase for its lead product,…

ActavisFinancialLicensingNeurologicalPharmaceuticalQRxPharmaRegulation

Back to top